Michael Davidov

1.2k total citations
44 papers, 872 citations indexed

About

Michael Davidov is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Michael Davidov has authored 44 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Michael Davidov's work include Blood Pressure and Hypertension Studies (22 papers), Hormonal Regulation and Hypertension (11 papers) and Cardiovascular Syncope and Autonomic Disorders (6 papers). Michael Davidov is often cited by papers focused on Blood Pressure and Hypertension Studies (22 papers), Hormonal Regulation and Hypertension (11 papers) and Cardiovascular Syncope and Autonomic Disorders (6 papers). Michael Davidov collaborates with scholars based in United States, Netherlands and Puerto Rico. Michael Davidov's co-authors include Frank A. Finnerty, William J. Mroczek, W. Robert Lee, James F. Burris, Richard P. Ames, William B. Applegate, Atul Laddu, Ross D. Fletcher, Robert DiBianco and Steven Singh and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Michael Davidov

43 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Davidov United States 19 505 174 119 113 101 44 872
H P Dustan United States 18 585 1.2× 247 1.4× 160 1.3× 157 1.4× 117 1.2× 45 1.1k
L. Terzoli Italy 15 572 1.1× 119 0.7× 193 1.6× 69 0.6× 71 0.7× 41 831
G Muiesan Italy 18 626 1.2× 160 0.9× 161 1.4× 195 1.7× 89 0.9× 88 1.1k
Gerald R. Dreslinski United States 16 825 1.6× 122 0.7× 120 1.0× 80 0.7× 58 0.6× 25 1.0k
D Magometschnigg Austria 15 708 1.4× 196 1.1× 167 1.4× 121 1.1× 49 0.5× 65 1.0k
Z. Glück Switzerland 14 347 0.7× 120 0.7× 245 2.1× 96 0.8× 108 1.1× 24 671
J. I. M. Drayer United States 16 781 1.5× 158 0.9× 249 2.1× 89 0.8× 45 0.4× 32 1.1k
William J. Mroczek United States 16 438 0.9× 139 0.8× 159 1.3× 49 0.4× 71 0.7× 50 686
Helen C. Mitchell United States 12 545 1.1× 96 0.6× 172 1.4× 160 1.4× 245 2.4× 23 832
Ibrahim M. Khatri United States 15 438 0.9× 270 1.6× 83 0.7× 124 1.1× 83 0.8× 18 968

Countries citing papers authored by Michael Davidov

Since Specialization
Citations

This map shows the geographic impact of Michael Davidov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Davidov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Davidov more than expected).

Fields of papers citing papers by Michael Davidov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Davidov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Davidov. The network helps show where Michael Davidov may publish in the future.

Co-authorship network of co-authors of Michael Davidov

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Davidov. A scholar is included among the top collaborators of Michael Davidov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Davidov. Michael Davidov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ram, Chirag, Richard P. Ames, William B. Applegate, et al.. (1994). Double‐blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension. Clinical Cardiology. 17(5). 251–256. 11 indexed citations
2.
Davidov, Michael, Sant P. Singh, Nicolas D. Vlachakis, et al.. (1994). Bisoprolol, a once‐a‐day beta‐blocking agent for patients with mild to moderate hypertension. Clinical Cardiology. 17(5). 263–268. 15 indexed citations
3.
Schoenberger, James A., William H. Frishman, John D. Wallin, et al.. (1989). Dilevalol compared with propranolol and placebo for systemic hypertension. The American Journal of Cardiology. 63(19). I45–I49. 8 indexed citations
4.
Schoenberger, James A., John D. Wallin, Michael Davidov, et al.. (1989). A Multicenter Double-Blind Study of the Efficacy and Safety of Once and Twice Daily Dilevalol Compared to Propranolol. American Journal of Hypertension. 2(11 Pt 1). 840–846. 1 indexed citations
5.
Shepherd, Alexander M. M., Albert A. Carr, Michael Davidov, et al.. (1989). Efficacy and Safety of Isradipine in Hypertension. Journal of Cardiovascular Pharmacology. 13(4). 580–585. 15 indexed citations
6.
Davidov, Michael, et al.. (1988). Comparison of Betaxolol, a New  1-Adrenergic Antagonist, to Propranolol in the Treatment of Mild to Moderate Hypertension. American Journal of Hypertension. 1(3 Pt 3). 206S–210S. 11 indexed citations
7.
Burris, James F., Richard P. Ames, William B. Applegate, et al.. (1988). Double-Blind Comparison of Amlodipine and Hydrochlorothiazide in Patients with Mild to Moderate Hypertension. Journal of Cardiovascular Pharmacology. 12(Supplement 7). S98–S102. 21 indexed citations
8.
Davidov, Michael, et al.. (1987). Serum magnesium and potassium levels in hypertensive patients after a therapeutic switch from hydrochlorothiazide plus a potassium supplement to maxzide. The American Journal of Medicine. 82(3). 48–51. 4 indexed citations
9.
Davidov, Michael. (1985). Acebutolol in essential hypertension: Results of two multicenter studies against placebo and propranolol. American Heart Journal. 109(5). 1158–1167. 9 indexed citations
10.
Davidov, Michael, et al.. (1976). The Effect of Nitroglycerin Ointment on the Exercise Capacity in Patients with Angina Pectoris. Angiology. 27(4). 205–211. 29 indexed citations
11.
Mroczek, William J., W. Robert Lee, Michael Davidov, & Frank A. Finnerty. (1976). Vasodilator administration in the presence of beta-adrenergic blockade.. Circulation. 53(6). 985–988. 15 indexed citations
12.
Lee, W. Robert, William J. Mroczek, Michael Davidov, & Frank A. Finnerty. (1975). Nonemergency use of slow infusions of diazoxide. Clinical Pharmacology & Therapeutics. 18(2). 154–157. 8 indexed citations
13.
Davidov, Michael, et al.. (1975). Long Term Follow-Up of Aggressive Medical Therapy of Accelerated Hypertension With Azotemia. Angiology. 26(5). 396–407. 19 indexed citations
14.
Mroczek, William J., et al.. (1974). Antihypertensive efficacy of metolazone. Clinical Pharmacology & Therapeutics. 16(2). 318–321. 3 indexed citations
15.
Mroczek, William J., et al.. (1969). The Value of Aggressive Therapy in the Hypertensive Patient with Azotemia. Circulation. 40(6). 893–904. 89 indexed citations
16.
Finnerty, Frank A., et al.. (1968). Relation of Sodium Balance to Arterial Pressure During Drug-Induced Saluresis. Circulation. 37(2). 175–183. 20 indexed citations
17.
Finnerty, Frank A., et al.. (1968). THE LONG TERM EFFECT OF REPEATED ACUTE REDUCTIONS OF ARTERIAL PRESSURE WITH DIAZOXIDE IN PATIENTS WITH SEVERE HYPERTENSION*. Annals of the New York Academy of Sciences. 150(2). 461–463. 8 indexed citations
18.
Davidov, Michael, et al.. (1967). The antihypertensive effects of an imidazoline compound. Clinical Pharmacology & Therapeutics. 8(6). 810–816. 50 indexed citations
19.
Davidov, Michael, et al.. (1967). Antihypertensive Properties of Furosemide. Circulation. 36(1). 125–135. 39 indexed citations
20.
Davidov, Michael, et al.. (1967). DIAZOXIDE AND FRUSEMIDE IN HYPERTENSION. The Lancet. 290(7518). 725–725. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H P Dustan Breakdown of academic impact, for papers by L. Terzoli Breakdown of academic impact, for papers by G Muiesan Breakdown of academic impact, for papers by Gerald R. Dreslinski Breakdown of academic impact, for papers by D Magometschnigg Breakdown of academic impact, for papers by Z. Glück Breakdown of academic impact, for papers by J. I. M. Drayer Breakdown of academic impact, for papers by William J. Mroczek Breakdown of academic impact, for papers by Helen C. Mitchell Breakdown of academic impact, for papers by Ibrahim M. Khatri
Rankless by CCL
2026